Publications
- Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003–20062011 | First Faculty of Medicine
- Safety of Biological Therapy During Pregnancy in Women with Inflammatory Bowel DiseasePublication without faculty affiliation
- Safety of Biological Therapy During Pregnancy in Women with Inflammatory Bowel Disease.Publication without faculty affiliation
- Tofacitinib in pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood and Breast Milk Concentrations2024 | First Faculty of Medicine, Second Faculty of Medicine
- Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?2023 | First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- News in gastroenterology, hepatology and digestive endoscopy2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Recommendations of the Working Group for IBD for the Diagnosis and Drug Treatment of Ulcerative Colitis2022 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Third Faculty of Medicine
- Safety of vedolizumab and ustekinumab in the treatment of pregnant women with inflammatory bowel disease - a multicentre retrospective-prospective observational study2022 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Central Library of Charles University
- Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study2022 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Central Library of Charles University
- Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study2022 | Faculty of Physical Education and Sport, First Faculty of Medicine, Second Faculty of Medicine
Loading network view...